Medical Marijuana (MJNA) Stock Price, News & Analysis

Company Overview

Medical Marijuana Inc (OTCMKTS:MJNA) is a publicly traded holding company focused on the research, cultivation, production and distribution of cannabis and hemp-based products. Through its subsidiaries, the company develops and markets cannabidiol (CBD) formulations, oils, tinctures, nutritional supplements and topical applications for human and animal wellness. Its business model encompasses both direct‐to‐consumer online sales and partnerships with multi‐level marketing organizations to expand reach and brand awareness.

The company’s flagship subsidiary, HempMeds®, produces CBD products derived from industrial hemp that comply with U.S. federal regulations, offering a range of capsules, tinctures and creams designed to address general health and well‐being. Another key unit, Kannaway®, employs a network marketing approach targeting global markets with nutritional and cosmetic items infused with hemp extracts. Additional affiliates focus on product innovation, quality control and supply chain management, ensuring consistency and regulatory compliance across all offerings.

Founded in 2009 and headquartered in San Diego, California, Medical Marijuana Inc evolved from hydroponics supply operations into a pioneering force in the emerging legal cannabis and hemp sector. The company has cultivated strategic partnerships and distribution channels across North and South America, Europe and parts of Asia, seeking to capitalize on evolving regulatory frameworks and growing consumer interest in alternative health solutions. It also invests in clinical research initiatives to better understand the potential applications of CBD in pain management, epilepsy and other conditions.

Under the leadership of CEO Dr. Stuart Titus, Medical Marijuana Inc has emphasized corporate governance, transparency and product integrity. The management team comprises professionals with backgrounds in pharmaceuticals, biotechnology, regulatory affairs and consumer marketing. Together, they aim to position the company as a trusted provider of hemp‐derived wellness products while pursuing long‐term growth opportunities in a dynamic global marketplace.

Key Stats

• Today's Range: $0.0002 to $0.0003
• 50-Day Range: N/A
• 52-Week Range: $0.0001 to $0.0017
• Volume: 43.45 million shs
• Average Volume: 28.39 million shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Medical Marijuana Stock Analysis - MarketRank™

Medical Marijuana scored higher than 3% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: N/A
• Analyst Rating: N/A

Consensus Rating

There is not enough analysis data for Medical Marijuana.

Earnings and Valuation

• Score: 0.0 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of Medical Marijuana is -0.04, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Medical Marijuana is -0.04, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Short Interest

• Score: 2.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

Medical Marijuana has a short interest ratio ("days to cover") of 0, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Medical Marijuana has recently increased by 240.22%, indicating that investor sentiment is decreasing significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Medical Marijuana does not currently pay a dividend.

Dividend Growth

Medical Marijuana does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

Medical Marijuana has a short interest ratio ("days to cover") of 0, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Medical Marijuana has recently increased by 240.22%, indicating that investor sentiment is decreasing significantly.

News and Social Media

• Score: 2.4 / 5
• News Sentiment: 0.38

News Sentiment

Medical Marijuana has a news sentiment score of 0.38. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 1.01 average news sentiment score of Medical companies.

News Coverage This Week

MarketBeat has tracked 2 news articles for Medical Marijuana this week, compared to 2 articles on an average week.

Search Interest

2 people have searched for MJNA on MarketBeat in the last 30 days. This is an increase of 100% compared to the previous 30 days.

MarketBeat Follows

4 people have added Medical Marijuana to their MarketBeat watchlist in the last 30 days. This is an increase of 300% compared to the previous 30 days.

Company Ownership

• Score: 0.0 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Medical Marijuana insiders have not sold or bought any company stock.

Percentage Held by Institutions

Only 0.03% of the stock of Medical Marijuana is held by institutions.

MJNA Stock Analysis - Frequently Asked Questions

How have MJNA shares performed this year?

Medical Marijuana's stock was trading at $0.0004 at the beginning of the year. Since then, MJNA stock has decreased by 25.0% and is now trading at $0.0003.

How do I buy shares of Medical Marijuana?

Shares of MJNA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Medical Marijuana own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Medical Marijuana investors own include Curaleaf (CURLF), Trulieve Cannabis (TCNNF), Clean Energy Fuels (CLNE), Vapor (HCMC), Grayscale Ethereum Trust (ETH) (ETHE), Vale (VALE) and Greenlane (GNLN).

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Drug Manufacturers - Specialty & Generic
• Sub-Industry: Cannabis
• Current Symbol: OTCMKTS:MJNA
• CIK: N/A
• Web: www.medicalmarijuanainc.com
• Phone: (866) 273-8502
• Fax: N/A
• Employees: 91
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A